# TRODELVY

NDC: 55135-132
Generic name: SACITUZUMAB GOVITECAN
Labeler / Manufacturer: Gilead Sciences, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20200422

FDA application: BLA761115

## Active ingredients

- SACITUZUMAB GOVITECAN: 180 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55135-132"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55135-132
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=57a597d2-03f0-472e-b148-016d7169169d